Published in Eur J Clin Microbiol Infect Dis on January 01, 1991
Current perspectives on glycopeptide resistance. Clin Microbiol Rev (1995) 2.99
Pathogenic relevance of Lactobacillus: a retrospective review of over 200 cases. Eur J Clin Microbiol Infect Dis (2005) 2.21
Lactobacillus species identification, H2O2 production, and antibiotic resistance and correlation with human clinical status. J Clin Microbiol (1999) 1.22
Lactobacillus rhamnosus bacteremia: an emerging clinical entity. Eur J Clin Microbiol Infect Dis (2012) 1.13
Lactobacillemia: an emerging cause of infection in both the immunocompromised and the immunocompetent host. J Natl Med Assoc (2000) 1.12
Lactobacillus species as emerging pathogens in neutropenic patients. Eur J Clin Microbiol Infect Dis (1997) 0.99
Antibiotic susceptibility of potentially probiotic vaginal lactobacilli. Infect Dis Obstet Gynecol (2006) 0.93
Identification of vancomycin-resistant lactic bacteria isolated from humans. J Clin Microbiol (1993) 0.90
Coagulase-negative staphylococci emerging during teicoplanin therapy and problems in the determination of their sensitivity. J Antimicrob Chemother (1991) 2.74
Multiplex real-time PCR and blood culture for identification of bloodstream pathogens in patients with suspected sepsis. Clin Microbiol Infect (2009) 2.28
Infections following peripheral blood progenitor cell transplantation for lymphoproliferative malignancies: etiology and potential risk factors. Am J Med (1999) 2.13
Non-Hodgkin's lymphoma in very elderly patients over 80 years. A descriptive analysis of clinical presentation and outcome. Ann Oncol (2007) 1.75
The syndrome of abnormal chromatin clumping in leucocytes: a myelodysplastic disorder with proliferative features? Br J Haematol (1988) 1.42
Subclinical late cardiomyopathy after doxorubicin therapy for lymphoma in adults. J Clin Oncol (2004) 1.37
Epileptic seizures after autologous peripheral blood progenitor infusion in a patient treated with high-dose chemotherapy for myeloma. Bone Marrow Transplant (2002) 1.33
Fatal septic shock with multiple organ failure due to Campylobacter jejuni. Clin Infect Dis (1996) 1.02
Comparison of cell wall teichoic acid fractions isolated from three different encapsulated strains of Staphylococcus epidermidis. Ann Microbiol (Paris) (1984) 0.96
Epidemiology of Staphylococcus aureus in patients with cystic fibrosis. Epidemiol Infect (1994) 0.94
High CD34(+) cell counts decrease hematologic toxicity of autologous peripheral blood progenitor cell transplantation. Blood (1998) 0.93
Saccharomyces boulardii fungemia in a patient receiving Ultra-levure therapy. Clin Infect Dis (1998) 0.92
POEMS syndrome, arterial thrombosis and thrombocythaemia. J Intern Med (1996) 0.92
[Pseudomonas pickettii septicemia]. Pathol Biol (Paris) (1985) 0.90
Osteomyelitis due to Corynebacterium group D2. Eur J Clin Microbiol Infect Dis (1991) 0.87
Intensive therapy with peripheral blood progenitor cell transplantation in 60 patients with poor-prognosis follicular lymphoma. Blood (1995) 0.86
Antibiotic resistance among anaerobic Gram-negative bacilli: lessons from a French multicentric survey. Anaerobe (2003) 0.85
Rituximab-related late-onset neutropenia after autologous stem cell transplantation for aggressive non-Hodgkin's lymphoma. Bone Marrow Transplant (2004) 0.84
A randomised phase II study of the efficacy, safety and cost-effectiveness of pegfilgrastim and filgrastim after autologous stem cell transplant for lymphoma and myeloma (PALM study). Eur J Cancer (2012) 0.83
Amifostine reduces mucosal damage after high-dose melphalan conditioning and autologous peripheral blood progenitor cell transplantation for patients with multiple myeloma. Bone Marrow Transplant (2002) 0.83
Autoimmune thrombocytopenic purpura after autologous stem cell transplantation. Bone Marrow Transplant (2003) 0.83
Heterogeneity of acute lymphoblastic leukemia in HIV-seropositive patients. Ann Oncol (1994) 0.83
Frequency of pseudocoagulase production in Staphylococcus aureus. Zentralbl Bakteriol Mikrobiol Hyg A (1984) 0.83
Intensive therapy with peripheral stem cell transplantation in 16 patients with mantle cell lymphoma. Ann Oncol (1997) 0.82
[Sensitivity to antibiotics of 64 strains of Stomatococcus mucilaginosus isolated in human clinical cases. Demonstration of erythromycin resistance]. Pathol Biol (Paris) (1988) 0.81
Influence of atmospheric conditions during incubation on the susceptibilities of Streptococcus pneumoniae isolates to five beta-lactam antibiotics. J Antimicrob Chemother (1997) 0.81
Automated detection of nosocomial infections: evaluation of different strategies in an intensive care unit 2000-2006. J Hosp Infect (2011) 0.81
Massive mediastinal extramedullary hematopoiesis in hereditary spherocytosis: a case report. Am J Hematol (1990) 0.81
Human B-lymphocyte heteroantigens: direct evidence for specificities not shared by monocytes. Clin Exp Immunol (1978) 0.80
Reduced progression-free survival in elderly patients receiving intensification with autologous peripheral blood stem cell reinfusion for multiple myeloma. Bone Marrow Transplant (1998) 0.80
[Nasopharyngeal carriage of Streptococcus pneumoniae in healthy children, 2 to 24 months of age, in New-Caledonia]. Med Mal Infect (2005) 0.80
Prevention of high dose L-PAM-induced mucositis by cryotherapy. Bone Marrow Transplant (1994) 0.79
Specific anti-hairy cell and anti-B cell antisera: characterization of surface antigens and origin of hairy cells. Clin Exp Immunol (1980) 0.79
Reappraisal of the effect of temperature on the growth kinetics of Aeromonas salmonicida. Lett Appl Microbiol (1997) 0.79
[Value of the study of fibrinogen affinity in the identification of Staphylococcus aureus. Results of a multicenter study]. Pathol Biol (Paris) (1983) 0.77
Isepamicin once daily plus ceftriaxone versus amikacin plus ceftriaxone in febrile neutropenic patients. J Chemother (1995) 0.77
Pneumocystis pneumonia in a patient treated with fludarabine for chronic lymphocytic leukemia. Eur J Cancer (1991) 0.77
The superoxide dismutase content in erythrocytes predicts short-term toxicity of high-dose cyclophosphamide. Br J Haematol (2001) 0.77
[Pneumococcus observatory data in the Rhône-Alps region. Results from 1996]. Pathol Biol (Paris) (1999) 0.77
[Pneumococcal antibiotic resistance in 1999. Results from 19 registries for 1999]. Presse Med (2001) 0.77
Severe autoimmune hemolytic anemia in two patients treated with fludarabine for chronic lymphocytic leukemia. Ann Oncol (1992) 0.76
Septic arthritis caused by Bacteroides fragilis in the setting of postlithiasis pyelonephritis. Clin Infect Dis (1992) 0.76
Comparative in vitro activity of penicillin G, levofloxacin, moxifloxacin, telithromycin, pristinamycin, quinupristin-dalfopristin and linezolid against ofloxacin-intermediate and -resistant Streptococcus pneumoniae. Clin Microbiol Infect (2002) 0.76
[Primary subcutaneous nocardiosis complicating nephrotic syndrome under corticosteroid therapy]. Presse Med (1987) 0.76
Skin lesions in malignancy. Case 3. Yellow nail syndrome in non-Hodgkin's lymphoma. J Clin Oncol (2001) 0.76
Intensive radio-chemotherapy with peripheral blood stem cell transplantation in young patients with chronic lymphocytic leukemia. Bone Marrow Transplant (1992) 0.76
[Recurrence of typhoid fever in an adolescent treated with ceftriaxone]. Arch Pediatr (1995) 0.75
Pseudodiffuse-type growth of a Staphylococcus aureus strain in serum-soft agar. J Clin Microbiol (1985) 0.75
[Can one use probabilistic protocols for antibiotic therapy in intensive care units?]. Pathol Biol (Paris) (1999) 0.75
Evaluation of Salmonella and Shigella identification with the MS2-BID automatic system. Zentralbl Bakteriol Mikrobiol Hyg A (1982) 0.75
Toxicities after peripheral blood progenitor cell transplantation for lymphoid malignancies: analysis of 300 cases in a single institution. Bone Marrow Transplant (1999) 0.75
[Comparison of the results of the Etest and the method for determining minimum inhibitory concentrations in solid media for penicillin G, amoxicillin, and cefotaxime for S. pneumoniae. A multicenter study]. Pathol Biol (Paris) (1998) 0.75
[Major pancytopenia in Biermer disease. 5 cases]. Ann Med Interne (Paris) (1994) 0.75
Isolation of Sporosarcina ureae from a bronchial biopsy in a child with cystic fibrosis. Eur J Clin Microbiol Infect Dis (1990) 0.75
[Critical analysis of the different methods for the determination of aminoglycosides. Application to follow-up of treatment]. Nouv Presse Med (1982) 0.75
[Relapse of Staphylococcus aureus septicemia due to the emergence ofa fluoroquinolone-resistant mutant]. Presse Med (1990) 0.75
[Haemophilus influenzae caused by cervical cellulitis in adults]. Presse Med (1986) 0.75
Alveolar cell carcinoma following treatment of acute non-lymphocytic leukaemia. Eur J Med (1994) 0.75
[Occurrence of a circulating anticoagulant, factor V inhibitor after surgical intervention]. Ann Fr Anesth Reanim (1989) 0.75
[Evaluation of a rapid technique for antibiotic sensitivity testing using an MS-2 automate and blood culture medium]. Ann Biol Clin (Paris) (1981) 0.75
[Evans syndrome, pseudotumoral lymphoid hyperplasia and deficit of IgA-IgG2-IgG4]. Presse Med (1995) 0.75
Peripheral blood stem cells harvested after chemotherapy and GM-CSF for treatment intensification in patients with advanced lymphoproliferative diseases. Leukemia (1993) 0.75
Intra-cytoplasmic crystalline inclusions in acute myeloid leukemia: a rare event. Scand J Haematol (1986) 0.75
Source of infection in Stomatococcus mucilaginosus septicaemia. Lancet (1990) 0.75
[Three cases of acute agranulocytosis: caused by minaprine?]. Presse Med (1993) 0.75
[Neurosarcoma associated with neurofibromatosis 1. Apropos of a case and review of the literature]. Presse Med (1997) 0.75
[IgM kappa gastric plasmacytoma]. Gastroenterol Clin Biol (1989) 0.75
[The use of teicoplanin in neutropenic patients: values and limits]. Pathol Biol (Paris) (1990) 0.75
[Comparison of the results of antibiograms obtained from blood culture broth and after isolation on agar media with the Autobac 1]. Ann Biol Clin (Paris) (1983) 0.75
[Significance of the isolation of Stomatococcus mucilaginosus]. Presse Med (1988) 0.75
[Amikacin in the treatment of febrile complications occurring during the neutropenic phase of acute hemopathies]. Nouv Presse Med (1979) 0.75
[Peritonitis with Mycobacterium avium complex in a patient with alcoholic cirrhosis]. Gastroenterol Clin Biol (2000) 0.75
[Evaluation of a rapid technic for antibiotic sensitivity testing: reproducibility of minimal inhibitory concentrations routinely estimated with the use of Abbott MS-2 autoanalyzer]. Ann Biol Clin (Paris) (1983) 0.75
Identification of a rare e8a2 BCR-ABL fusion gene in three novel chronic myeloid leukemia patients treated with imatinib. Leukemia (2005) 0.75
Stomatococcus mucilaginosus meningitis in a child with leukemia. Clin Infect Dis (1992) 0.75
[Detection of Pseudomonas cytochrome oxidase and esterase in blood culture broths]. Pathol Biol (Paris) (1984) 0.75
Variations in morphological and immunological blast cell phenotype in a case of acute leukaemia with t(4;11) translocation. Acta Haematol (1986) 0.75
[Septicemia and multiple abscesses of the liver caused by Streptococcus anginosus]. Nouv Presse Med (1982) 0.75
[Renal amyloidosis disclosing Waldenström's macroglobulinemia]. Presse Med (1984) 0.75
Corynebacterium JK: surgical infections in non-immunosuppressed patients. Intensive Care Med (1988) 0.75
[Pharmacokinetic study of pefloxacin in 37 hospital patients under resuscitation]. Pathol Biol (Paris) (1985) 0.75
[Identification of Staphylococcus aureus by the sero-inhibition of nuclease in blood culture broths]. Pathol Biol (Paris) (1985) 0.75
[Monitoring of antibiotic resistance of gram negative anaerobes]. Med Mal Infect (2008) 0.75
[Comparison of various characters and antigenic structure in S. aureus strains cultivated in hospitalized patients and in healthy carriers]. Rev Epidemiol Sante Publique (1979) 0.75
A prospective study of intensive induction therapy with high-dose consolidation in patients with aggressive non-Hodgkin's lymphoma and two or three adverse prognostic factors. Leukemia (2000) 0.75